Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 6
2004 7
2005 4
2006 1
2007 4
2008 2
2010 1
2011 2
2012 4
2013 2
2014 5
2015 4
2016 5
2017 2
2018 2
2019 4
2020 11
2021 11
2022 14
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution.
Suma S, Suehara Y, Fujisawa M, Abe Y, Hattori K, Makishima K, Sakamoto T, Sawa A, Bando H, Kaji D, Sugio T, Kato K, Akashi K, Matsue K, Carreras J, Nakamura N, Suzuki A, Suzuki Y, Ito K, Shiiba H, Chiba S, Sakata-Yanagimoto M. Suma S, et al. Among authors: bando h. Leukemia. 2024 Feb;38(2):340-350. doi: 10.1038/s41375-023-02093-7. Epub 2023 Nov 27. Leukemia. 2024. PMID: 38012392 Free PMC article.
Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
Hoshi A, Bando H, Sekine I. Hoshi A, et al. Among authors: bando h. N Engl J Med. 2021 Oct 7;385(15):1439-1440. doi: 10.1056/NEJMc2112373. N Engl J Med. 2021. PMID: 34614337 No abstract available.
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling.
Abe Y, Sakata-Yanagimoto M, Fujisawa M, Miyoshi H, Suehara Y, Hattori K, Kusakabe M, Sakamoto T, Nishikii H, Nguyen TB, Owada Y, Enomoto T, Sawa A, Bando H, Yoshida C, Tabata R, Terao T, Nakayama M, Ohshima K, Usuki K, Oda T, Matsue K, Chiba S. Abe Y, et al. Among authors: bando h. Nat Cell Biol. 2022 Apr;24(4):565-578. doi: 10.1038/s41556-022-00866-3. Epub 2022 Mar 24. Nat Cell Biol. 2022. PMID: 35332263 Free PMC article.
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
Iihara H, Shimokawa M, Bando H, Niwa Y, Mizuno Y, Kawaguchi Y, Kitahora M, Murakami A, Kawai M, Ishida K, Takeuchi M, Ishihara K, Iyoda T, Nakada T, Ogiso A, Kojima Y, Kumagai F, Sawa A, Mori R, Higuchi K, Furuta T, Kamei Y, Tsuchiya M, Terasaki A, Yamamoto S, Kitazawa M, Okazaki M, Suzuki A, Futamura M. Iihara H, et al. Among authors: bando h. J Cancer. 2023 Aug 28;14(14):2644-2654. doi: 10.7150/jca.87169. eCollection 2023. J Cancer. 2023. PMID: 37779870 Free PMC article.
Trastuzumab: updates and future issues.
Toi M, Horiguchi K, Bando H, Saji S, Chow LW. Toi M, et al. Among authors: bando h. Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:94-9. doi: 10.1007/s00280-005-0110-8. Cancer Chemother Pharmacol. 2005. PMID: 16273357 Review.
Current status of antibody therapy for breast cancer.
Toi M, Takada M, Bando H, Toyama K, Yamashiro H, Horiguchi S, Saji S. Toi M, et al. Among authors: bando h. Breast Cancer. 2004;11(1):10-4. doi: 10.1007/BF02967994. Breast Cancer. 2004. PMID: 14718785 Review.
93 results